Cargando…
Supersaturated state of diazepam injection following dilution with infusion fluid
BACKGROUND: Significant precipitation produced by the dilution of diazepam (DZP) injection with an infusion fluid is a great concern for the clinical practice. In this study, the precipitation behavior under different conditions was investigated. METHOD: For the sample preparation, DZP injections (H...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728752/ https://www.ncbi.nlm.nih.gov/pubmed/26819720 http://dx.doi.org/10.1186/s40780-014-0009-9 |
_version_ | 1782412171000414208 |
---|---|
author | Onuki, Yoshinori Hasegawa, Naoki Kida, Chihiro Ikegami-Kawai, Mayumi Tsubuki, Masayoshi Shirozu, Shunsuke Obata, Yasuko Takayama, Kozo |
author_facet | Onuki, Yoshinori Hasegawa, Naoki Kida, Chihiro Ikegami-Kawai, Mayumi Tsubuki, Masayoshi Shirozu, Shunsuke Obata, Yasuko Takayama, Kozo |
author_sort | Onuki, Yoshinori |
collection | PubMed |
description | BACKGROUND: Significant precipitation produced by the dilution of diazepam (DZP) injection with an infusion fluid is a great concern for the clinical practice. In this study, the precipitation behavior under different conditions was investigated. METHOD: For the sample preparation, DZP injections (Horizon injection and Cercine injection) were diluted with various infusion fluids (Saline, 5% glucose infusion fluid and Soldem 3A) at designated dilution ratios ranging from 1× to 40× (5 mg/mL to 0.125 mg/mL). In addition, to measure the solubility of DZP in the samples, the saturated solutions of DZP were prepared. The DZP concentrations in the samples were measured by high-performance liquid chromatography (HPLC). This study also investigated the precipitate using various analytical methods: infrared microscopy, (1)H-NMR, differential scanning calorimetry, and powder X-ray deflection. RESULTS: First, the compatibility of injection with infusion fluids was investigated. Significant precipitation occurred at dilution ratios ranging from 2× to 20×. No significant effects of formulations and infusion fluids on the compatibility were observed. The solubility of DZP was then further investigated. The concentration of DZP dissolved in the admixtures was higher than the solubility. This indicated that DZP existed in a supersaturated state in the infusion fluid admixtures. In the next phase of this study, the precipitate was investigated using various analytical methods. Results showed that the precipitate in infusion fluid admixtures was mostly composed of DZP, but also contained small amounts of the ingredients of DZP injection, such as benzoic acid and benzyl alcohol. CONCLUSIONS: This study clarified details of the precipitation occurring after dilution of DZP injection with infusion fluids. It is worth noting that DZP in an infusion admixture existed in a supersaturated state. These findings offer important insight into the clinical practice of DZP injection. |
format | Online Article Text |
id | pubmed-4728752 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47287522016-01-27 Supersaturated state of diazepam injection following dilution with infusion fluid Onuki, Yoshinori Hasegawa, Naoki Kida, Chihiro Ikegami-Kawai, Mayumi Tsubuki, Masayoshi Shirozu, Shunsuke Obata, Yasuko Takayama, Kozo J Pharm Health Care Sci Research Article BACKGROUND: Significant precipitation produced by the dilution of diazepam (DZP) injection with an infusion fluid is a great concern for the clinical practice. In this study, the precipitation behavior under different conditions was investigated. METHOD: For the sample preparation, DZP injections (Horizon injection and Cercine injection) were diluted with various infusion fluids (Saline, 5% glucose infusion fluid and Soldem 3A) at designated dilution ratios ranging from 1× to 40× (5 mg/mL to 0.125 mg/mL). In addition, to measure the solubility of DZP in the samples, the saturated solutions of DZP were prepared. The DZP concentrations in the samples were measured by high-performance liquid chromatography (HPLC). This study also investigated the precipitate using various analytical methods: infrared microscopy, (1)H-NMR, differential scanning calorimetry, and powder X-ray deflection. RESULTS: First, the compatibility of injection with infusion fluids was investigated. Significant precipitation occurred at dilution ratios ranging from 2× to 20×. No significant effects of formulations and infusion fluids on the compatibility were observed. The solubility of DZP was then further investigated. The concentration of DZP dissolved in the admixtures was higher than the solubility. This indicated that DZP existed in a supersaturated state in the infusion fluid admixtures. In the next phase of this study, the precipitate was investigated using various analytical methods. Results showed that the precipitate in infusion fluid admixtures was mostly composed of DZP, but also contained small amounts of the ingredients of DZP injection, such as benzoic acid and benzyl alcohol. CONCLUSIONS: This study clarified details of the precipitation occurring after dilution of DZP injection with infusion fluids. It is worth noting that DZP in an infusion admixture existed in a supersaturated state. These findings offer important insight into the clinical practice of DZP injection. BioMed Central 2015-03-09 /pmc/articles/PMC4728752/ /pubmed/26819720 http://dx.doi.org/10.1186/s40780-014-0009-9 Text en © Onuki et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Onuki, Yoshinori Hasegawa, Naoki Kida, Chihiro Ikegami-Kawai, Mayumi Tsubuki, Masayoshi Shirozu, Shunsuke Obata, Yasuko Takayama, Kozo Supersaturated state of diazepam injection following dilution with infusion fluid |
title | Supersaturated state of diazepam injection following dilution with infusion fluid |
title_full | Supersaturated state of diazepam injection following dilution with infusion fluid |
title_fullStr | Supersaturated state of diazepam injection following dilution with infusion fluid |
title_full_unstemmed | Supersaturated state of diazepam injection following dilution with infusion fluid |
title_short | Supersaturated state of diazepam injection following dilution with infusion fluid |
title_sort | supersaturated state of diazepam injection following dilution with infusion fluid |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728752/ https://www.ncbi.nlm.nih.gov/pubmed/26819720 http://dx.doi.org/10.1186/s40780-014-0009-9 |
work_keys_str_mv | AT onukiyoshinori supersaturatedstateofdiazepaminjectionfollowingdilutionwithinfusionfluid AT hasegawanaoki supersaturatedstateofdiazepaminjectionfollowingdilutionwithinfusionfluid AT kidachihiro supersaturatedstateofdiazepaminjectionfollowingdilutionwithinfusionfluid AT ikegamikawaimayumi supersaturatedstateofdiazepaminjectionfollowingdilutionwithinfusionfluid AT tsubukimasayoshi supersaturatedstateofdiazepaminjectionfollowingdilutionwithinfusionfluid AT shirozushunsuke supersaturatedstateofdiazepaminjectionfollowingdilutionwithinfusionfluid AT obatayasuko supersaturatedstateofdiazepaminjectionfollowingdilutionwithinfusionfluid AT takayamakozo supersaturatedstateofdiazepaminjectionfollowingdilutionwithinfusionfluid |